KPF
CORV

K2 Principal Fund’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

K2 Principal Fund’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13,579
Closed -$128K – 216
2015
Q2 		$128K Buy
+13,579
New +$127K 0.02% 163

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

K2 Principal Fund's CORV Position: Q3 2015 in Review

K2 Principal Fund sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q3 2015, closing a stake of 13,579 shares — an estimated $128K sold.

K2 Principal Fund first reported a position in CORV in Q2 2015 and held it in 1 quarter. The position peaked at $128K in Q2 2015. 30 funds tracked by Wall St. Rank hold CORV as of Q3 2015.

  • K2 Principal Fund reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q3 2015 after selling out during the quarter.
  • K2 Principal Fund sold 13,579 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q3 2015, an estimated $128K.
  • K2 Principal Fund first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2015 and held it in 1 quarter.
  • K2 Principal Fund's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $128K in Q2 2015.
  • 30 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q3 2015.

Based on K2 Principal Fund's 13F filing for Q3 2015, filed 13 Nov 2015.